Why is Torrent Pharma falling/rising?

As of 09-Jul, Torrent Pharmaceuticals Ltd. is experiencing a price increase, with the current price at 3,351.00, reflecting a rise of 33.0 or 0.99%. The stock has shown a trend reversal, gaining after two consecutive days of decline. Today's performance indicates that it has outperformed its sector by 0.79%, and there has been a notable increase in investor participation, with delivery volume rising by 45.62% compared to the 5-day average. Over the past year, the stock has generated a return of 14.39%, significantly outperforming the BSE500 index in recent years, which suggests strong investor confidence. Additionally, the company has demonstrated high management efficiency with a return on capital employed (ROCE) of 22.33% and a low debt-to-EBITDA ratio of 1.26 times, indicating a strong ability to service its debt.
In the broader market context, the stock's short-term performance has been slightly negative, with a 1-week return of -0.01%, while the benchmark Sensex has gained 0.15% in the same period. However, over the last month, Torrent Pharmaceuticals has outperformed the benchmark with a return of 5.33% compared to the Sensex's 1.32%. This suggests that despite some recent volatility, the stock is positioned well in the market, supported by consistent positive results over the last seven quarters and high institutional holdings at 24.66%, which typically indicates a robust analysis of the company's fundamentals by more sophisticated investors.